PEB - Pacific Edge Ltd

[psychic]

I'm guessing you didn't buy in 15 months ago at 14c?

The balls-up of the Capital raising aside - and it's price and terms - I like to think it may be a sign of expansionism to meet building demand. They do have $20m in cash to help fund current operations. Q1 throughput and cash receipts were double the previous quarter so my guess is that they need another lab and more staff. Q2 and Aus listing will tell the story. Watching and Waiting.
Disc. Holder from way back (15 months ago).

Brain noted prev page that the US lab was good for 250000pa tests. They managed about 5000 tests last qtr worldwide, so a new lab would seem unlikely in the US? $70m ? That is a lot of fitout...

[psychic]

Why would PEB price their tests higher than a cystoscopy at a doctors office, and why are medical facilities like Kaiser adopting Cxbladder when they could do it cheaper in house. Think about it

You have zero evidence that KP have adopted. Saying they have a commercial agreement is one thing, adoption is another.
I have asked the question here before why the test is so expensive in the US.
The model works here in NZ at 1/3rd the price. Anyway, I've thought about it, what's the answer?

[LoungeLizzard]

Brain noted prev page that the US lab was good for 250000 tests. They managed about 5000 tests last qtr worldwide, so a new lab would seem unlikely in the US? $70m ? That is a lot of fitout...

But if throughput is double from last 1/4 and treble from a year ago - and only PEB know what may be coming down the pipe as far as acceptance by other providers is concerned - wouldn't they have to be thinking 1-2 years ahead? You don't get train new staff and get lab accreditation at the drop of a hat.

[psychic]

Double off a tiny base. Nothing.
**actually ...
Total Laboratory Throughput in Q1 FY22 was:
Up 79% on Q1 FY21
Up 9% on Q4 FY21
Up 35% on quarterly average from FY21

Oh yeah, and remember they were bleating on about how Q1 21 was down because of covid anyway right?

[LoungeLizzard]

If you are paying $US7,000 a year in premiums - the average in the US - as a client you are not going to opt for a cheap invasive procedure, when there is a non-invasive procedure available with equal or better detection rate. And in the US - as long as you have insurance - you do have the choice. For Kaiser they will have looked at the ratio of people opting for a hospital procedure compared to the cheaper in-office procedure and have worked out that CXBladder is cheaper OVERALL.

[psychic]

But there is not the confidence that Cxbladder offers an equal or better detection rate.
They are not there yet

[LoungeLizzard]

Double off a tiny base. Nothing.
**actually ...
Total Laboratory Throughput in Q1 FY22 was:
Up 79% on Q1 FY21
Up 9% on Q4 FY21
Up 35% on quarterly average from FY21

Oh yeah, and remember they were bleating on about how Q120 was down because of covid anyway right?

From PEB:

"Laboratory throughput has risen consistently over the last five quarters § 179% on the same time last year
§ 109% on the preceding quarter (Q4 FY21)
Cash Receipts from Customers also continue to grow as reimbursement success and volumes grow.
§ 242% on the same time last year
§ 121% on the preceding quarter (Q4 FY21)"





The jury is still out but SP doesn't lie - so far the market likes what it is hearing. Let's wait for Q2 eh?

[Balance]

You have zero evidence that KP have adopted. Saying they have a commercial agreement is one thing, adoption is another.
I have asked the question here before why the test is so expensive in the US.
The model works here in NZ at 1/3rd the price. Anyway, I've thought about it, what's the answer?

Is it because anything connected with healthcare in the US is damn expensive?

A good example :

https://www.nbcnews.com/health/healt...after-n1278934

But at $10 or $15 a test, the price is still far too high for regular use by anyone but the wealthy. A family with two school-age children might need to spend $500 or more a month to try to keep its members — and others — safe.

For Americans looking for swift answers, the cheapest over-the-counter Covid test is the Abbott Laboratories BinaxNOW two-pack, for $23.99. Close behind are Quidel's QuickVue tests, at $15 a pop.
In Germany, grocery stores sell rapid tests for under $1 apiece. In India, they're about $3.50. The U.K. provides 14 tests per person free of charge. Canada is doling out free rapid tests to businesses.

[psychic]

The figures I have quoted are the same only you have read them to be up 109% when what they mean is the quarter was 109% of previous (ie up 9%)

And yeah, share prices do lie, particularly when mislead and misunderstood. And there is buckets of both here.

(oops sorry - in reply to earlier post lounge lizard)

[psychic]

Is it because anything connected with healthcare in the US is damn expensive?

A good example :

https://www.nbcnews.com/health/healt...after-n1278934

But at $10 or $15 a test, the price is still far too high for regular use by anyone but the wealthy. A family with two school-age children might need to spend $500 or more a month to try to keep its members — and others — safe.

For Americans looking for swift answers, the cheapest over-the-counter Covid test is the Abbott Laboratories BinaxNOW two-pack, for $23.99. Close behind are Quidel's QuickVue tests, at $15 a pop.
In Germany, grocery stores sell rapid tests for under $1 apiece. In India, they're about $3.50. The U.K. provides 14 tests per person free of charge. Canada is doling out free rapid tests to businesses.

Thanks. Yes perhaps that is part of it? Interesting to see the article notes how expensive a PCR test is at $100, well ahh - isn't that what Cxbladder is?

PE were quoted as charging something like $1500 for a while there before the CMS rate was set. I just don't get it. Surely if your hope is to nibble into the cystoscopy market then the cost of that would be a consideration? The CMS rate for office cystoscopy is like $240. Add a cheap cytology test and you have the gold standard.